Phenotypic detection of multidrug-resistance pseudomonas aeruginosa isolated from various clinical samples
Keywords:
multi-drug resistance Pseudomonas aeruginosa (MDRPA), extended spectrum β-lactamase (ESBL), metallo β-Lactamase (MBL), disc potentiation testAbstract
Introduction: β-Lactamase production is considered one of the most important resistance mechanisms among virulent Pseudomonas aeruginosa isolates. The aim of the study was to detect Extended Spectrum β-Lactamase (ESBL) and Metallo β-Lactamase (MBL) in Pseudomonas aeruginosa obtained from various clinical samples. Materials and Methods: The study was conducted in the Department of Microbiology, Govt. Medical College, Shahdol. All clinical specimens were processed and P. aeruginosa isolates were identified by standard protocols. Antibiotic sensitivity testing for all isolates was done using Kirby-Bauer disc diffusion method. Detection of ESBL and MBL was done by Disc potentiation test. Results: Among 347(27.2%) isolates of P. aeruginosa, 284(88.2%) were MDR, 139(40%) and 73(21%) were ESBL and MBL producers respectively where 39(11.2%) isolates produced both ESBL and MBL. Conclusion: A high prevalence of MDR, ESBL, MBL positive isolates among P. aeruginosa is increasing at an alarming rate. Thus, proper antibiotic policy and measures to restrict the indiscriminative use of cephalosporins and carbapenems should be taken to minimize the emergence of this MDRPA.
Downloads
References
Jefferies JMC, Cooper T, Yam T, Clarke SC. Pseudomonas aeruginosa outbreaks in the neonatal intensive care unit – a systematic review of risk factors and environmental sources. J Med. Microbiol. 2012;61:1052–1061. [PubMed] [Google Scholar]
Lister PD, Wolter DJ, Hanson ND. Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev. 2009;22:582–610. [PMC free article] [PubMed] [Google Scholar]
Church D, Elsayed S, Reid O, Winston B, Lindsay R. Burn wound infections. Clin Microbiol Rev. 2006;19:403–434. [PMC free article] [PubMed] [Google Scholar]
Sorde R, Pahissa A, Rello J. Management of refractory Pseudomonas aeruginosa infection in cystic fibrosis. Infect Drug Resist. 2011;4:31–41. [PMC free article] [PubMed] [Google Scholar]
Strateva T, Yordanov D. Pseudomonas aeruginosa - a phenomenon of bacterial resistance. J Med Microbiol. 2009;58:1133–1148. [PubMed] [Google Scholar]
Z. A.Memish, A.M. Shibl,A. M.Kambal, Y. A. Ohaly,A. Ishaq, and D. M. Livermore, “Antimicrobial resistance among nonfermenting gram-negative bacteria in Saudi Arabia,” Journal of Antimicrobial Chemotherapy, vol. 67, no. 7, Article ID dks091, 2012; pp. 1701–1705.
A. O. Okesola and A. A. Oni, “Occurrence of Extended-Spectrum Beta-Lactamase-Producing Pseudomonas aeruginosa Strains in South-West Nigeria,” Research Journal of Medical Sciences, vol. 6, no. 3, 2012; pp. 93–96.
P. Gladstone, P. Rajendran, and K. N. Brahmadathan, “Incidence of carbapenem resistant nonfermenting gram negative bacilli from patients with respiratory infections in the intensive
care units,” Indian Journal of Medical Microbiology, vol. 23, no. 3, 2005; pp. 189–191.
A. Hodiwala, R. Dhoke, and A. D. Urhekar, “Incidence of metallo-beta-lactamase producing Pseudomonas, Acinetobacter and enterobacterial isolates in hospitalised patients,” International Journal of Pharmacy and Biological Sciences, vol. 3, 2013; pp. 79–83.
Taslima Y. Prevalence of ESβL among E. coli and Klebsiella Spp. in a tertiary care hospital and molecular detection of important ESβL producing genes by multiplex PCR. PhD, Mymensingh Medical College, Mymensingh, Bangladesh; 2012.
J. G. Collee and W. Marr, “Specimen collection, culture containers and media,” inMackie andMcCartney Practical Medical Microbiology, G. J. Collee, G. A. Fraser, B. P. Marmon, and A. Simmons, Eds., pp. 14–27, Elsevier, Toronto, Canada.
Patrica MT (2014). Bailey and Scott's Diagnostic Microbiology, Thirteenth Edition, Elsevier Inc, pp 329-345.
Clinical Laboratory and Standard Institute (2015). Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fifth Informational Supplement 35: 3.
Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al., (2012). Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect.; 18: 268-281.
M. Banerjee, B. L. Chaudhary, and S. Shukla, “Prevalence of ESBL and MBL in Acinetobacter species isolated from clinical samples in a tertiary care hospital,” Proceedings of the International Journal of Science and Research, vol. 4, no. 6, 2015; pp. 1183–1186.
C. Sadhana, W. Smita, D. Charan, and A. S. Khare, “Antibiotic resistance pattern of Pseudomonas aeruginosawith special reference to Imipenem and metallo-beta lactamase production,”Indian Journal of Basic and AppliedMedical Research, vol. 4, no.1, 2014;pp. 117–122,.
Micek ST, Lloyd AE, Ritchie DJ, Reichley RM, Fraser VJ, Kollef MH. Pseudomonas aeruginosa bloodstream infection: Importance of appropriate initial antimicrobial treatment. Antimicrob Agents Chemother 2005;49:1306-11.
Rajat RM, Ninama GL, Mistry K, Parmar R, Patel K, Vegad MM. Antibiotic resistance pattern in Pseudomonas aeruginosa species isolated at a tertiary care Hospital, Ahmadabad. Natl J Med Res 2012;2:156-9.
Javiya VA, Ghatak SB, Patel KR, Patel JA. Antibiotic susceptibility patterns of Pseudomonas aeruginosa at a tertiary care hospital in Gujarat, India. Indian J Pharmacol 2008;40:230-4.
Srinivas B, Devi DL, Rao BN. A Prospective study of Pseudomonas aeruginosa and its Antibiogram in a Teaching Hospital of Rural setup. J Pharm Biomed Sci 2012;22:1-4.
Okon KO, Agukwe PC, Oladosu W, Balogun ST, Uba A. Antibiotic resistance pattern of Pseudomonas aeruginosa isolated from clinical specimens in a tertiary care hospital in Northeastren Nigeria. Internet J Microbiol 2010;8:1-6.
Dash M, Padhi S, Narasimham MV, Pattnaik S. Antimicrobial resistance pattern of Pseudomonas aeruginosa isolated from various clinical samples in a tertiary care hospital, South Odisha, India. Saudi J Health Sci 2014;3:15-9.
Mohanasoundaram KM. The antimicrobial resistance pattern in the clinical isolates of Pseudomonas aeruginosa in a tertiary care hospital; 2008-2010 (A 3 yr study). J Clin Diagn Res 2011;5:491-4.
Gill MM, Usman J, Kaleem F, Hassan A, Khalid A, Anjum R, et al. Frequency and antibiogram of multi-drug resistant Pseudomonas aeruginosa. J Coll Physicians Surg Pak 2011;21:531-4.
Mohanasundaram KM. The antimicrobial resistance pattern in the clinical isolates of Pseudomonas aeruginosa in a tertiary care hospital: 2008-2010(a 3 year study) Journal of Clinical and Diagnostic Research. 2011;Vol-5(3):491–94. [Google Scholar]
Ayse Yüce, Nur Yapar, Oya Eren Kutsoylu. Evaluation of antibiotic resistance patterns of pseudomonas aeruginosa and Acinetobacter spp. strains isolated from intensive care patients between 2000-2002 and 2003-2006 periods in Dokuz Eylul University Hospital. Izmir Mikrobiyol Bul. 2009;43(2):195–202. [PubMed] [Google Scholar]
Ibukun A, Tochukwu N, Tolu O. Occurrence of ESBL and MBL in clinical isolates of Pseudomonas aeruginosa From Lagos, Nigeria. Journal of American Science. 2007;3(4):81–85. [Google Scholar]
Diwivedi M, Mishra A, Singh RK, Azim A, Baronia AK, Prasad KN. The nosocomial cross – transmission of Pseudomonas aeruginosabetween patients in a tertiary intensive care unit. Indian J Pathol Microbiol. 2009;52(4):509–13. [PubMed] [Google Scholar]
Arya M, Arya P, Biswas D, Prasad R. The antimicrobial susceptibility pattern of the bacterial isolates from post-operative wound infections. Indian J Pathol Microbiol. 2005;48(2):266–69. [PubMed] [Google Scholar]
Goel Varun, Sumati A, Hogade SG, Karadesai Prevalence of extended-spectrumbeta-lactamases, AmpC beta—lactamase,and metallo—beta—lactamase producing Pseudomonas aeruginosa and Acinetobacterbaumannii in an intensive care unit in a tertiary. Care Hospital Journal of the Scientific Society. 2013;40(1):28–31. [Google Scholar]
Peshattiwar Prashant Durwas, Basavaraj Virupaksappa Peerapur. ESBLand MBL mediated resistance in Pseudomonas aeruginosa: an emerging threat to clinical therapeutics. Journal of Clinical and Diagnostic Research. 2011;Vol-5(8):1552–554. [Google Scholar]
Aggarwal R, Chaudhary U, Bala K. Detection of extended—spectrum beta—lactamase in Pseudomonas aeruginosa. Indian J Pathol Microbiol. 2008;51:222–4. [PubMed] [Google Scholar]
Chaudhari U, Bhaskar H, Sharma M. The Imipenem-EDTA disk method for the rapid identification of metallo β lactamase producing gram negative bacteria. IndianJ Med Res. 2008;127(2):406–07. [PubMed] [Google Scholar]
S. Upadhyay, M. R. Sen, and A. Bhattacharjee, “Presence of different beta-lactamase classes among clinical isolates of Pseudomonas aeruginosa expressing AmpC beta-lactamase
enzyme,” The Journal of Infection in Developing Countries, vol. 4, no. 4, 2010 ;pp. 239–242.
M. Sharma, S. Sarita, and U. Chaudhary, “Metallo-beta-lactamase producing Pseudomonas aeruginosa in neonatal septicemia,” Journal of Laboratory Physicians, vol. 2, 2010 no.1, p.14.
B. Behera, P. Mathur, A. Das, A. Kapil, and V. Sharma, “An evaluation of four different phenotypic techniques for detection of metallo-????-lactamase producing Pseudomonas aeruginosa,” Indian Journal of Medical Microbiology, vol. 26, no. 3, , 2008; pp. 233–237.
S. Aggarwal, P. Durlabhji, and S. Gupta, “Incidence of Metallo- ????-lactamase producing Pseudomonas aeruginosa isolates and their antimicrobial susceptibility pattern in clinical samples from a tertiary care hospital,” International Journal of Research and Review, vol. 4, no.1, 2017; pp. 92–98.
Suwija, N., Suarta, M., Suparsa, N., Alit Geria, A.A.G., Suryasa, W. (2019). Balinese speech system towards speaker social behavior. Humanities & Social Sciences Reviews, 7(5), 32-40. https://doi.org/10.18510/hssr.2019.754
Widana, I.K., Sumetri, N.W., Sutapa, I.K., Suryasa, W. (2021). Anthropometric measures for better cardiovascular and musculoskeletal health. Computer Applications in Engineering Education, 29(3), 550–561. https://doi.org/10.1002/cae.22202
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
